Found: 5
Select item for more details and to access through your institution.
CeVi: A UNIQUE CRYOPRESERVED HUMAN VIABLE CELL COLLECTION FROM LYMPHOMA PATIENTS, A CALYM INITIATIVE TO ACCELERATE INNOVATION AND ITS TRANSFER TO LYMPHOMA FIELD.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 370, doi. 10.1002/hon.38_2631
- By:
- Publication type:
- Article
FEASIBILITY AND BENEFIT OF MOLECULARLY‐INFORMED ENROLLMENT INTO EARLY PHASE CLINICAL TRIALS FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 330, doi. 10.1002/hon.142_2630
- By:
- Publication type:
- Article
CeVi: A UNIQUE CRYOPRESERVED HUMAN VIABLE CELL COLLECTION FROM LYMPHOMA PATIENTS, A CALYM INITIATIVE TO ACCELERATE INNOVATION AND ITS TRANSFER TO LYMPHOMA FIELD.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 370, doi. 10.1002/hon.38_2631
- By:
- Publication type:
- Article
FEASIBILITY AND BENEFIT OF MOLECULARLY‐INFORMED ENROLLMENT INTO EARLY PHASE CLINICAL TRIALS FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 330, doi. 10.1002/hon.142_2630
- By:
- Publication type:
- Article
Molecular landscape of relapse/refractory diffuse large B-cell lymphoma.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 279, doi. 10.1002/hon.2439_4
- By:
- Publication type:
- Article